Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05542836 · ClinicalTrials.gov registry record

EVeRLAST 2-Year Follow-Up

A clinical trial of Pelvic Organ Prolapse, sponsored by Duke University.

Completed
Registry status
63
Enrollment target
1
Study location

NCT05542836 is a study of Pelvic Organ Prolapse that has completed, run by Duke University. The registered enrollment target is 63 participants, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05542836, a study of Pelvic Organ Prolapse, has completed, sponsored by Duke University.

COMPLETED
Registry status
63 participants
Enrollment target
1
Study location

Study Summary

This is a 2-year follow-up study from EVeRLAST which objective was to determine whether expedited resumption of postoperative activity levels is non-inferior to standard activity restrictions with respect to short-term anatomic prolapse outcomes. The preliminary data from the original study suggest expedited instructions are non-inferior. We hypothesize this effect continues at the 2-year postoperative mark and patients continue to have non-inferior outcomes after prolapse surgery when compared to standard postoperative activity restrictions. Participants from the original EVeRLAST will be approached to assess their interest in participating in the 2-year follow up study. We will be collecting objective and subjective data.

Conditions Studied

Interventions

  • BEHAVIORAL Expedited postoperative activity instructions
  • BEHAVIORAL Standard postoperative activity restructions

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2022-09-30
Est. Completion 2023-09-27

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05542836

The ClinicalTrials.gov registry entry for NCT05542836 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (56% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 2 interventions - of which Expedited postoperative activity instructions is the first listed.

NCT05542836 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05542836 about?

NCT05542836 is a clinical study titled "EVeRLAST 2-Year Follow-Up". This is a 2-year follow-up study from EVeRLAST which objective was to determine whether expedited resumption of postoperative activity levels is non-inferior to standard activity restrictions with respect to short-term anatomic prolapse outcomes. The preliminary data from the original study suggest ...

What is the current status of trial NCT05542836?

This trial is currently completed. The enrollment target is 63 participants. The study started on 2022-09-30. Estimated completion is 2023-09-27.

What conditions does trial NCT05542836 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse.

What interventions are being tested in trial NCT05542836?

The interventions under investigation include: Expedited postoperative activity instructions (BEHAVIORAL), Standard postoperative activity restructions (BEHAVIORAL).

Who is sponsoring clinical trial NCT05542836?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05542836 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.